Growth hormone-releasing peptide (Ghrelin), a new endogenous brain-gut peptide consisting of 28 amino acids, has a role in inhibiting insulin secretion, regulating blood glucose values, and has neuroprotective and anti-apoptotic activity in neurological diseases. The gene discussed is GHRL; the disease is nervous system disorder.